These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694 [TBL] [Abstract][Full Text] [Related]
8. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Whittemore VH; Thiele EA; Ford JP; Shah G; Cauwel H; Lebwohl D; Sahmoud T; Jozwiak S Lancet; 2013 Jan; 381(9861):125-32. PubMed ID: 23158522 [TBL] [Abstract][Full Text] [Related]
10. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report. Beaumont TL; Godzik J; Dahiya S; Smyth MD J Neurosurg Pediatr; 2015 Aug; 16(2):134-7. PubMed ID: 25978531 [TBL] [Abstract][Full Text] [Related]
11. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843 [TBL] [Abstract][Full Text] [Related]
12. Subependymal giant cell astrocytoma in a genetically negative tuberous sclerosis complex adult: Case report. Konakondla S; Jayarao M; Skrade J; Giannini C; Workman MJ; Morgan CJ Clin Neurol Neurosurg; 2016 Nov; 150():177-180. PubMed ID: 27690251 [TBL] [Abstract][Full Text] [Related]
13. Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Curran MP Paediatr Drugs; 2012 Feb; 14(1):51-60. PubMed ID: 22136276 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]